| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |